Protalix BioTherapeutics, Inc. ikhonkco yemakethe

Protalix BioTherapeutics, Inc. i-capital capital

Namhlanje i-market capital Protalix BioTherapeutics, Inc. ingu-185 914 448 US dollar.

+5 164 288 $ (+2.86%)

utshintsho lwentengo ukususela ngezolo

Ulwazi lwe Protalix BioTherapeutics, Inc. capitalisation ithathwe kwimithombo evulekileyo. Ngokusekwe kurhwebo lwexabiso lesitokhwe Protalix BioTherapeutics, Inc. kwintengiso yokuthengiselana ngesitokhwe, unokuvavanya ubupapasho be- Protalix BioTherapeutics, Inc.. Olu lwazi lolwazi malunga Protalix BioTherapeutics, Inc. capitalization. Protalix BioTherapeutics, Inc., i-capitalisation - 185 914 448 iidola zaseMelika.

Protalix BioTherapeutics, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa Protalix BioTherapeutics, Inc. lingama-1 693 588 US dollar.

-3 716 112 $ (-68.69%)

utshintsho lwendleko yorhwebo ukususela ngezolo

Protalix BioTherapeutics, Inc. ivolumu yokurhweba namhlanje ikho 1 693 588 iidola zaseMelika. Protalix BioTherapeutics, Inc. ithengiswa kuthengiso lweevenkile ezahlukeneyo. Itshathi yemihla ngemihla yeklasi ye- Protalix BioTherapeutics, Inc. ivolumu yokurhweba ihanjiswa kwiwebhusayithi yethu. Protalix BioTherapeutics, Inc. capitalisation inyukile xa ithelekiswa nezolo.

Bonisa: Protalix BioTherapeutics, Inc. (PLX) Ukuze US dollar (USD)

Protalix BioTherapeutics, Inc. istatshi yekhredithi yemakethe

Protalix BioTherapeutics, Inc. eyinkunzi yentengiso kwigrafu ngeminyaka. 20% ngeveki - utshintsho kutshintsho lweentengiso Protalix BioTherapeutics, Inc.. Utshintsho ngaphakathi Protalix BioTherapeutics, Inc. capitalise ngenyanga ngu 0%. Namhlanje, Protalix BioTherapeutics, Inc. capitalization iqikelelwa 185 914 448 iidola zaseMelika.

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

Protalix BioTherapeutics, Inc. imbali yenkxaso-mali

Umhla	Ixabiso Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
04/05/2023	185 914 448 $
03/05/2023	180 750 160 $
02/05/2023	155 789 408 $
01/05/2023	166 404 912 $
28/04/2023	158 945 376 $
27/04/2023	151 485 840 $
26/04/2023	154 928 704 $

Protalix BioTherapeutics, Inc. isatifiketi somqulu

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

Protalix BioTherapeutics, Inc. idatha yembali yevolumu

Umhla	Umqulu (24h) Ixabiso lezorhwebo leProtalix BioTherapeutics, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-PLX ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
04/05/2023	1 693 588 $
03/05/2023	5 409 700 $
02/05/2023	2 165 417 $
01/05/2023	2 739 510 $
28/04/2023	1 777 766 $
27/04/2023	1 007 339 $
26/04/2023	3 157 284 $

Protalix BioTherapeutics, Inc. i-capital capital yase-US namhlanje 04/05/2023. 03/05/2023 Protalix BioTherapeutics, Inc. capitalization ilingane 180 750 160 iidola zaseMelika. 02/05/2023 Protalix BioTherapeutics, Inc. capitalisation ilingana 155 789 408 iidola zaseMelika. Protalix BioTherapeutics, Inc. capitalization ilingane 166 404 912 Iidola zaseMelika ku- 01/05/2023.

Vuliwe 28/04/2023, Protalix BioTherapeutics, Inc. capitalisation yayiyi- $ 158 945 376. Iimali yentengiso enkulu ye Protalix BioTherapeutics, Inc. kwi 27/04/2023 ifikelele kuthi 151 485 840 iidola zaseMelika. Iimali yentengiso enkulu ye Protalix BioTherapeutics, Inc. ifikelele kwi 154 928 704 Iidola zaseMelika ku- 26/04/2023.

Inkcitho ye-Protalix BioTherapeutics, Inc. namhlanje ngu-185 914 448 $. Iimali zentengiso ye-Protalix BioTherapeutics, Inc. ishintshile +2.86% xa kuthelekiswa nezolo. Imali yokuthengisa ye PLX izabelo ze Protalix BioTherapeutics, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-1 693 588 $. Ixabiso lokuthengiswa kwezabelo ze Protalix BioTherapeutics, Inc. latshintshile kwi--68.693% xa kuthelekiswa nosuku lwangaphambili lworhwebo.